|
DNAJC19 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6242562850266E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
4.39989999989621E-07 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
6.804300E-02 |
| Stage1-vs-Stage3 |
1.365220E-01 |
| Stage1-vs-Stage4 |
8.715100E-03 |
| Stage2-vs-Stage3 |
1.218490E-02 |
| Stage2-vs-Stage4 |
1.818070E-03 |
| Stage3-vs-Stage4 |
3.287800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
2.06449999984315E-07 |
| Normal-vs-Asian |
1.61960000966133E-10 |
| Caucasian-vs-AfricanAmerican |
3.074400E-01 |
| Caucasian-vs-Asian |
4.563800E-02 |
| AfricanAmerican-vs-Asian |
7.038600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.6242562850266E-12 |
| Male-vs-Female |
7.576200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.63058455626697E-12 |
| Normal-vs-Age(81-100Yrs) |
1.191460E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.259400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.472200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.733400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.165000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.286000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.685800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.652000E-02 |
| Classical-VS-Follicular |
2.91029999999193E-06 |
| Classical-VS-Other |
2.932000E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
1.47870000000161E-06 |
| Tall-VS-Other |
4.193600E-02 |
| Tall-VS-Normal |
1.81687997979907E-12 |
| Follicular-VS-Other |
2.409800E-01 |
| Follicular-VS-Normal |
6.08959999999215E-05 |
| Other-VS-Normal |
3.160100E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.39221967287995E-12 |
| Normal-vs-N1 |
1.99840144432528E-15 |
| N0-vs-N1 |
1.345620E-02 |
|
|
